NCT03792048 is a NA clinical trial of Magnetic Compressive Anastomosis in Cholangiocarcinoma, sponsored by First Affiliated Hospital Xi'an Jiaotong University.

Who is sponsoring NCT03792048?

NCT03792048 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT03792048?

Interventions in NCT03792048: Magnetic Compressive Anastomosis.

What condition does NCT03792048 study?

NCT03792048 studies Cholangiocarcinoma, Pancreatic Neoplasms, Duodenal Neoplasms, Pancreatolithiasis, Chronic Pancreatitis.

Is NCT03792048 still recruiting?

NCT03792048 is currently status unknown. Last updated 18 November 2019.

Last reviewed 2019-11-18 · How we verify

NCT03792048

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure

Status unknown NA Last updated 18 November 2019

What this trial tests

NA trial testing Magnetic Compressive Anastomosis in Cholangiocarcinoma in 50 participants. Status unknown.

Timeline

1 February 2019

Primary endpoint
31 January 2021

31 January 2022

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 February 2019
Primary completion	31 January 2021
Estimated completion	31 January 2022
Sites	2 locations across China

Drugs / interventions tested

Magnetic Compressive Anastomosis

Conditions studied

Cholangiocarcinoma — all drugs for Cholangiocarcinoma →
Pancreatic Neoplasms — all drugs for Pancreatic Neoplasms →
Duodenal Neoplasms — all drugs for Duodenal Neoplasms →
Pancreatolithiasis — all drugs for Pancreatolithiasis →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Adults 18 to 75, any sex, with Cholangiocarcinoma or Pancreatic Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Magnetic anastomosis has been attempted in biliary and intestinal reconstruction. Based on our initial experience, the investigators have successfully utilized magnetic anastomosis for biliojejunostomy and pancreaticojejunostomy during pancreaticoduodenectomy. The current study was to design a prospective and case-control study with utilization of magnetic compression anastomosis for pancreaticojejunostomy and biliojejunostomy in Whipple's procedure versus traditional hand-sewn technique on the postoperative morbidity, such as biliary/pancreatic fistula, hemorrhage, anastomotic stenosis, etc. In addition, the investigators are seeking to assess the safety and formation of the anastomosis by magnetic technique.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Laparoscopic-assisted full-sized liver transplantation with magnetically fast portal vein anastomosis: an initial cohort study.
Liu XM, Li Y, Feng Z, Zhang XG, et al · · 2024 · cited 1× · PMID 38814355 · DOI 10.1097/js9.0000000000001730

Verify or expand the search:

Other trials of Magnetic Compressive Anastomosis

Trials testing the same drug.

NCT03774589 — Bilioenteric Anastomosis by Magnetic Compressive Technique · NA · unknown

Other recruiting trials for Cholangiocarcinoma

Currently open trials in the same condition.

NCT07486713 — Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies · Phase 4 · recruiting
NCT07291947 — PULSAR Combined With Immunotherapy and Chemotherapy · Phase 1, PHASE2 · recruiting
NCT07359586 — Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia · recruiting
NCT07263217 — Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury · NA · recruiting
NCT07155525 — Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas · Phase 3 · recruiting

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03792048 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 18 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03792048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing